CDK6 and central nervous system cancer: Over-expression of miR-495 in glioma cells downregulates the expression of cyclin-dependent kinase 6 (CDK6) and inhibits retinoblastoma phosphorylation, and knockdown of CDK6 results in cell cycle arrest at the G1/S transition and inhibition of cell proliferation [67].